The hormone leptin is a regulator of bone remodeling, a homeostatic function maintaining bone mass constant. Mice lacking molecular-clock components (Per and Cry), or lacking Per genes in osteoblasts, display high bone mass, suggesting that bone remodeling may also be subject to circadian regulation. Moreover, Per-deficient mice experience a paradoxical increase in bone mass following leptin intracerebroventricular infusion. Thus, clock genes may mediate the leptin-dependent sympathetic regulation of bone formation. We show that expression of clock genes in osteoblasts is regulated by the sympathetic nervous system and leptin. Clock genes mediate the antiproliferative function of sympathetic signaling by inhibiting G1 cyclin expression. Partially antagonizing this inhibitory loop, leptin also upregulates AP-1 gene expression, which promotes cyclin D1 expression, osteoblast proliferation, and bone formation. Thus, leptin determines the extent of bone formation by modulating, via sympathetic signaling, osteoblast proliferation through two antagonistic pathways, one of which involves the molecular clock.
Introduction
Bone remodeling, the physiological process whereby bone mass is maintained constant during adulthood, is comprised of two phases. There is first a rapid phase of resorption of preexisting mineralized bone by osteoclasts, the bone-resorbing cells, followed by a relatively slow phase of de novo bone formation by osteoblasts, the bone-forming cells (Rodan and Martin, 2000) . Osteoblasts have another function during bone remodeling: they control osteoclast differentiation. Bone remodeling, which is only partially understood at the molecular level, is disrupted in several frequent skeletal degenerative diseases. That one of these diseases, os-*Correspondence: karsenty@bcm.tmc.edu 6 These authors contributed equally to this work. teoporosis, is the most prevalent degenerative disease in developed countries (Riggs and Melton, 1986 ) explains the extent of the research effort underway to elucidate the molecular bases of this physiological function.
As expected for such a dynamic and complex process, bone remodeling is tightly controlled through two types of regulation (Chien and Karsenty, 2005 ). The first is exerted locally by factors secreted by either osteoblasts or osteoclasts. These include, but are not limited to, RANK ligand and osteoprotegerin, which control osteoclast differentiation, and insulin-like growth factors and other mitogens that affect bone formation. The second level of regulation is exerted systemically by hormones, such as sex steroids, parathyroid hormone, and leptin, and by neural inputs. This systemic regulation often impinges upon the expression of local regulators of bone mass. Among the many systemic regulators, leptin is nearly unique, as it affects profoundly both arms of bone remodeling. After binding to its receptor on hypothalamic neurons, leptin regulates, by targeting only one cell type, the osteoblast, bone formation (via the sympathetic nervous system [SNS]), and osteoclast differentiation (via the SNS and cocaine-and amphetamine-regulated transcript, or CART) ( transcription factors, BMAL1 and CLOCK, that heterodimerize to stimulate the expression of other core circadian genes, such as Period (Per1, 2, and 3), Cryptochrome (Cry1 and 2), and Rev-Erbα. In the negativefeedback loop, PER and CRY proteins form a heteromultimeric complex with another core circadian regulator, casein kinase I⑀, translocate into the nucleus, and suppress Per, Cry, and Rev-Erbα transcription by directly inhibiting the activity of BMAL1/CLOCK heterodimers. The positive and negative loops are connected by REV-ERBα, which inhibits Bmal1 transcription through a retinoic-acid-related-orphan-receptor response element in the Bmal1 promoter. Importantly for our purpose, mutations in the genes mentioned above (hereafter collectively referred to as clock genes) affect circadian behavioral rhythmicity in mice without resulting, in most cases, in sterility or obesity (Emery and Reppert, 2004) .
In search of regulators of leptin functions in bone, we analyzed mice lacking clock components such as Per1 and 2 or Cry1 and 2 (Vitaterna et al., 1999; Zheng et al., 2001). Although these mutant mice developed a highbone-mass phenotype due to an increase in bone formation, there was no evidence that clock genes act upstream of leptin to inhibit bone formation. Instead, and through their expression in osteoblasts, clock genes mediate the leptin-dependent sympathetic inhibition of bone formation by suppressing the expression of G1 cyclins and osteoblast proliferation. Removal of molecular-clock function uncovered that leptin and sympathetic signaling exert a countervailing and stimulatory effect on osteoblast proliferation through the AP-1 family of transcription factors. Thus, regulation of bone formation by leptin comprises two antagonistic pathways whose combined actions determine the rate of osteoblast proliferation.
Results

High Bone Mass in Mice Lacking Per or Cry Genes
To determine whether clock genes regulate bone mass, we studied Per1-and 2-and Cry1-and 2-deficient mice (Vitaterna et al., 1999; Zheng et al., 2001 ). Although these mutant mice showed disrupted circadian behavioral rhythms, they have, unlike Clock-deficient mice (Turek et al., 2005) , normal body weight, fat-pad weight, food intake, fertility, and endocrine parameters ( Figure 1A and Figure S1 in the Supplemental Data available with this article online). Thus, they could be used to determine whether clock genes participate in the regulation of bone formation by leptin.
Mice lacking either Per gene (Per1 −/− or Per2 −/− ) or only the Per2 PAS domain (Per2 m/m ) had a normal bone mass as determined by histology and microcomputed tomography ( Figure 1B and data not shown). In contrast, starting at 6 weeks of age, Per1 −/− ;Per2 m/m mice showed a significant increase in bone mass (HBM) that affected both vertebrae and long bones, a phenotype that worsened over time (Figures 1B-1D) . A HBM of similar severity was also observed in double mutant mice lacking the entire Per2 gene (Per1 −/− ;Per2 −/− ), indicating that HBM in these mice was a loss-of-function phenotype (Figures 1B and 1C Figure 1E ).
To identify which arm of bone remodeling was affected by the loss of clock function, we performed biochemical and histomorphometric analyses. Urinary elimination of deoxypyridinoline crosslinks, a by-product of collagen degradation, was similar in wild-type (wt) and Per1 −/− ; Per2 m/m mice, indicating that bone resorption was not overtly affected in these mice ( Figure S2A ). In contrast, there was a significant increase in the number of osteoblasts and, consequently, in bone-formation parameters (mineral apposition rate and bone-formation rate) in Per Gene Expression, Function, and Regulation by Sympathetic Tone in Osteoblasts Consistent with the aforementioned hypothesis, Per1, Per2, Cry1, Bmal1, and Clock all showed robust, rhythmic expression over a 24 hr period in wt bones, and their expression was decreased and arrhythmic in Per1 −/− ;Per2 m/m bones, indicating that bone has a peripheral clock ( Figure 3A) . The expression of all clock genes was also detected in osteoblasts ( Figure S4A ). In contrast, the expression of Npas2, whose deletion does not affect bone mass (M.S.P. and G.K., unpublished data), was not detected in bone or osteoblasts, although it was detected easily in liver (data not shown).
To determine whether Per genes regulate bone mass by acting in osteoblasts, we engineered an osteoblastspecific inactivation of Per2 on a Figure S4D) , and, when plated at the same density, Per1 −/− ;Per2 m/m osteoblasts grew faster than wt osteoblasts, resulting in a larger cell population at the end of a 5-day culture period (Figure 4A) .
To study cell-cycle progression in wt and Per1 −/− ; Per2 m/m osteoblasts, cells were synchronized in G1 phase by serum starvation, then refed with fresh medium to initiate cell proliferation. Sixteen hours after refeeding, synchronized Per1 −/− ;Per2 m/m osteoblasts had a 2-fold increase in G2 population as determined by flow cytometry, whereas wt osteoblasts showed an increase in S but not G2 population ( Figure 4B but had no effect in Adrβ2 −/− mice. Such a glaring discrepancy between two models that should phenocopy each other could be best explained if sympathetic signaling exerts two regulatory actions on osteoblast proliferation, one negative through the clock genes and another positive through yet-to-be-identified genes.
In an effort to identify these genes, we studied the expression of transcription factors that affect osteoblast differentiation and/or proliferation. As shown in Figure 5A , among all the genes tested, c-fos, a gene that can induce osteoblast transformation ( 
Leptin Regulates the Expression of AP-1 and Clock Genes In Vivo
The last question we asked was whether the sympathetic regulation of osteoblast proliferation via the clock and AP-1 genes occurs under the control of leptin signaling. To that end, we used ob/ob mice, a mutant mouse strain that lacks leptin and responds to leptin i.c.v. infusion with dramatic phenotypic, cellular, and molecular consequences (Zhang et al., 1994) . We transiently infused leptin in the third ventricle of these mice and, after confirming the expected increase in urine norepinephrine excretion (Figure S4G) , studied gene expression in bone at various time points. As shown in Figure 6D , both Per2 and c-fos expression increased significantly following this acute injection of leptin, and the same was true for Clock and additional AP-1 genes (data not shown). These results established that expression of these genes is controlled, in part, by leptin.
Discussion
This study demonstrates that clock genes in osteoblasts mediate the leptin-dependent sympathetic inhibition of bone formation. It also uncovers that leptin-dependent sympathetic signaling in osteoblasts promotes cell proliferation by activating AP-1 gene expression (Figure 7 ) a function of leptin not uncovered by the analysis of ob/ob mice. The regulation of bone formation by leptin through two antagonistic pathways is reminiscent of the dual mechanism that leptin uses to regulate bone resorption (Elefteriou et al., 2005) .
A Candidate Gene Approach to Study Leptin's Antiosteogenic Function
Throughout the study of leptin's regulation of bone mass, we used a combination of two approaches: clinical observations for discovering a novel physiological pathway and reliance on candidate genes (Ducy et al., There is a functional hierarchy between the two sympathetic-dependent antagonistic pathways in osteoblasts, and two experimental arguments strongly suggest that the clock-mediated pathway plays the dominant role. First, increasing sympathetic tone by leptin i.c.v. infusion decreases osteoblast number in wt mice, a function ascribed here to the clock genes. Second, expression of multiple AP-1 genes is increased in the absence of Per genes, indicating that clock genes control directly and/or indirectly AP-1 expression (Figure 7) .
Unexpected Specificity of the Mediators of Leptin's Regulation of Bone Mass
A feature progressively emerging from the molecular dissection of leptin's regulation of bone mass is that its mediators are not involved in a significant manner in mediating leptin's other cardinal functions, such as control of appetite and reproduction, in unchallenged animals. This specificity of action is surprising in the case of clock genes, AP-1 genes, and Adrβ2, which are not osteoblast-specific genes. The narrow specificity of action of these mediators and the ability of leptin to regulate powerfully both aspects of bone remodeling, along with the fact that it first appeared during evolution in vertebrates, underscore the importance of leptin's regulation of bone mass and raise the prospect that this may have been the ancestral function of this hormone.
Experimental Procedures
Animal Maintenance
Mice were housed in 12 hr:12 hr light/dark cycles with light on at ZT0 and off at ZT12. Human leptin (Sigma; 8 ng/hr in PBS) or PBS was infused i.c.v. as described (Ducy et al., 2000) or transiently (3.5 g in 2 l over 6 min) using an infusion pump. Mice were injected with 25 mg/kg calcein 6 and 2 days prior to sacrifice, and histomorphometric analyses were performed as described (Kato et al., 2002) . Mice were injected i.p. with 15 l/g of 25 mM BrdU at ZT2 and ZT14 and were sacrificed 2 hr later, and BrdU was detected as previously described (Kato et al., 2002) .
Cell Culture
Stromal-cell and osteoblast progenitors were cultured according to Kato et al. (2002) . Primary osteoblasts were isolated as in Ducy et al. (1999) and cultured in αMEM with 10% FBS (Hyclone). Osteoblast growth curves were obtained by manual counting and by crystal violet staining. For cell-cycle studies, osteoblasts were collected after releasing from serum starvation or hydroxyurea (0.5 mM) block and pulse-chasing with BrdU (10 M, 30 min) at various times and analyzed by a Becton Dickinson FACScan flow cytometer following standard procedures. Lipofectamine (Invitrogen) was used for transient transfection assays, with β-gal cotransfection serving as a control.
RNA and Protein Analyses
RNA was prepared from cells treated with isoproterenol (10 M in PBS) for 20 min in αMEM/0.2% FBS or from bones using TriZOL. RPA was performed using the RiboQuant multiprobe RPA systems for mouse AP-1 and cyclin genes (BD Biosciences). Northern blots and RPAs were quantified using a Molecular Dynamics Storm 860 PhosphorImager/Fluorima. Real-time PCR was performed using an ABI Prism 7000 Sequence Detection System (Applied Biosystems) with probes and reagents supplied by the manufacturer. The level of expression for all mRNAs was normalized to that of 18S rRNA. Cyclin D1 was detected by Western blot using a cyclin D1-specific antibody (Santa Cruz Biotechnology) and an anti-β-actin antibody (Sigma) as a loading control. Electrophoretic mobility shift assays (EMSA) were performed following standard procedures.
Chemistry and Hormone Measurements
Leptin (Crystal Chem), estradiol (DSL), PTH (Immunotopics), insulin (Crystal Chem), calcium, and phosphate were measured using commercially available kits. Deoxypyridinoline crosslinks were measured in two consecutive morning urines (ZT3) per mouse (Metra Biosystems) in 6-month-old mice or 2 weeks after ovariectomy (OVX). Norepinephrine and epinephrine were measured in acidified spot urine samples by either TLC (Amersham) or RIA (Bi-CAT; Alpco) with similar results. Creatinine was used to standardize between urine samples.
Statistical Analyses
Statistical significance was assessed by Student's two-tailed t test. Values were considered statistically significant at p < 0.05. 
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